ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Agilent Technologies has agreed to acquire Billerica, Mass.-based Seahorse Bioscience for $235 million in cash. Seahorse makes analyzers that measure cell metabolism to better understand cell health, function, and signaling. Founded in 2001, it employs about 200 people and is expected to have sales of $49 million this year. Combining Seahorse’s metabolic analysis instruments with Agilent’s separations and mass spectrometry equipment will help scientists research challenging diseases, Agilent says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X